<DOC>
<DOCNO>
EP-0007643
</DOCNO>
<TEXT>
<DATE>
19800206
</DATE>
<IPC-CLASSIFICATIONS>
C07D-251/66 C07D-498/00 C07D-211/00 C07D-498/04 C07D-401/04 <main>C07D-498/04</main> C07D-211/98 C07D-251/00 A61K-31/53 
</IPC-CLASSIFICATIONS>
<TITLE>
oxadiazolotriazine derivatives.
</TITLE>
<APPLICANT>
hoffmann la rochech<sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaftpostfach 32554002 baselch<sep>f. hoffmann-la roche & co. aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
muller jean-claude dr<sep>ramuz henri dr<sep>muller, jean-claude dr.<sep>ramuz, henri dr.<sep>muller, jean-claude dr.27 rue albert schweitzerparc d'entremont, f-68170 rixheimfr<sep>ramuz, henri dr.rheinparkstrasse 3ch-4127 birsfeldench<sep>muller, jean-claude dr.<sep>ramuz, henri dr.<sep>muller, jean-claude dr.27 rue albert schweitzerparc d'entremont, f-68170 rixheimfr<sep>ramuz, henri dr.rheinparkstrasse 3ch-4127 birsfeldench<sep>
</INVENTOR>
<ABSTRACT>
New oxadiazolotriazinder derivatives of the formula wherein R¹ is hydrogen and R² one of the groups -C-R⁴, cooor⁵ and -CH (R⁶) coor⁷ or R¹ and R² have the same meaning and mean hydrogen or the group -CH (R⁶) coor⁷ and R³ diallylamino or 1,2,5,6-tetrahydropyridine-1-yl, R⁴ alkyl, haloalkyl, alko xyalkyl, aryloxyalkyl; Aralkyloxyalkyl, aralkyl, alkoxy carbonylalkyl, aryl, the group -C (R⁸) = CH (R⁹), alkoxy carbonylalkylcarbonyl or a 4 to 7-membered heterocyclic radical, which optionally bonds via a methylene group, R⁸ alkyl, alkoxyalkyl, aralkyl, Aryl or allyl, R⁶ hydrogen or alkyl, R⁷ alkyl and R⁸ and R⁹ per alkyl, aryl, aralkyl or a 4-to 7-membered heterocyclic radical, as well as their salts have long-lasting valuable vessels of serwanding and / or blood pressure-sensitive properties and are therefore suitable For the treatment of vascular hypertension or as vasodilators with peripheral circulatory disorders. These compounds can be prepared by various methods.
</ABSTRACT>
</TEXT>
</DOC>
